Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV.
about
Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologiesPreexposure chemoprophylaxis for HIV prevention in men who have sex with menIntegrating Antiretroviral Strategies for Human Immunodeficiency Virus Prevention: Post- and Pre-Exposure Prophylaxis and Early TreatmentPreparing for HIV pre-exposure prophylaxis: lessons learned from post-exposure prophylaxisChoice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic reviewPractical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial reviewStarter packs versus full prescription of antiretroviral drugs for postexposure prophylaxis: a systematic review.Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trialNo evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxisModeling the Slow CD4+ T Cell Decline in HIV-Infected IndividualsCandidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunitiesHIV prevalence among female sex workers, drug users and men who have sex with men in Brazil: a systematic review and meta-analysis.The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.Initial commitment to pre-exposure prophylaxis and circumcision for HIV prevention amongst Indian truck drivers.The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention.Preexposure prophylaxis and predicted condom use among high-risk men who have sex with menEffects of messaging about multiple biomedical and behavioral HIV prevention methods on intentions to use among US MSM: results of an experimental messaging study.Availability of HIV postexposure prophylaxis services in Los Angeles CountyUptake and repeat use of postexposure prophylaxis in a community-based clinic in Los Angeles, California.Use of non-occupational post-exposure prophylaxis does not lead to an increase in high risk sex behaviors in men who have sex with men participating in the EXPLORE trialHIV prevention for people who use substances: evidence-based strategies.Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with menHIV-1 drug resistance in the iPrEx preexposure prophylaxis trial.Current perspectives in HIV post-exposure prophylaxis.Occupational exposure to HIV and the use of post-exposure prophylaxis.Pre-exposure prophylaxis and the promise of combination prevention approachesChemoprophylaxis for HIV prevention: new opportunities and new questions.Subsequent HIV infection among men who have sex with men who used non-occupational post-exposure prophylaxis at a Boston community health center: 1997-2013A randomized noninferiority trial of standard versus enhanced risk reduction and adherence counseling for individuals receiving post-exposure prophylaxis following sexual exposures to HIVPre-exposure prophylaxis of HIV: A right way to go or a long way to go?Promising prevention approaches: tenofovir gel and prophylactic use of antiretroviral medications.Longitudinal trends in HIV nonoccupational postexposure prophylaxis use at a Boston community health center between 1997 and 2013.The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV PreventionPreventing human immunodeficiency virus infection among sexual assault survivors in Cape Town, South Africa: an observational studyMulticentre RCT and economic evaluation of a psychological intervention together with a leaflet to reduce risk behaviour amongst men who have sex with men (MSM) prescribed post-exposure prophylaxis for HIV following sexual exposure (PEPSE): a protocPre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.A novel combination HIV prevention strategy: post-exposure prophylaxis with contingency management for substance abuse treatment among methamphetamine-using men who have sex with men.Awareness of Post-Exposure Prophylaxis (PEP) and Pre-Exposure Prophylaxis (PrEP) Is Low but Interest Is High Among Men Engaging in Condomless Anal Sex With Men in Boston, Pittsburgh, and San Juan.HIV postexposure prophylaxis in sexual assault: current practice and patient adherence to treatment recommendations in a large urban teaching hospital.Beyond informed consent: ethical considerations in the design and implementation of sexual and reproductive health research among adolescents.
P2860
Q22252604-A6EE1572-9385-4961-95D8-58321341570FQ24612082-519DF347-E0D7-49BD-B6DE-4396102718BBQ26778085-2EB7AE94-6D18-4732-B8A8-628DCC733071Q26820865-CC1B9D85-598F-41D3-80FE-73E6B11E81C8Q26851448-A6736140-D6A2-4E2F-A359-54D4F09FBB00Q26853055-77F59EDF-113E-4036-A71E-F8B1CE8E1362Q27691370-E72CF737-DBB2-4984-877B-3A9A7C18FF93Q28469218-C0DD639E-962C-408F-9323-44D9C64C64F4Q28537713-C868EABA-E018-41C0-A4FC-9797829446E2Q28551803-24418736-9707-4708-8E7A-3F0007F2A306Q30226978-98CEB257-B257-4F49-8DD9-12B2D9A5E4BEQ30495341-2697CA81-9405-493E-AB56-C8C4C4BE16CCQ33332191-6D5BA942-5A50-4EA0-8ADC-831CEE48810BQ33650953-7470F2FC-E872-4A1F-8CA8-7E2F3764ED21Q33828458-85BD01D7-F5D6-4A91-8606-AF1239449582Q34012348-15182254-91EC-4BEC-AEC5-C963619D7711Q34022092-1B324BD1-F3A2-4F29-B185-2DDFF2E44E33Q34071050-555BF879-7CA2-47B8-AC39-82DB2166B325Q34116802-F9DDA3FF-8944-4CEE-AEF6-3D5AF681D80DQ34152689-208FC49D-4FEF-46CB-B038-FE81C311F382Q34154119-4AC42957-85C5-4C15-B5C6-5E3B96BA1A44Q34221145-D622E0BF-CBAA-4C54-AB12-9156A11875CBQ34249966-044A0E80-8487-4F70-8827-6528065F49F4Q34434815-7F75B782-0373-43FD-8F3A-0A0631EA8705Q34656428-44A10C27-6235-4471-8453-7F5AB4D9FBD4Q34724603-726643AE-654B-4543-A416-FB319E47AFEEQ34786284-AB9A3643-37C9-4B5D-9CAF-859292655BECQ34802731-5E89D234-3465-4727-B163-A24AC148C65FQ35031691-4789FF9E-0ED3-4446-821F-BB62FCA62926Q35033732-6ECF7D2C-E4C8-43A8-B9E3-06529B8C20CFQ35619304-B917BF8A-468E-4FA9-9AA2-2D98F1F18BB5Q35696557-255D9D42-C8FB-4441-BF67-8265281B77F5Q35821208-816F7429-5BBD-4BC9-B724-341E80FCFAE3Q35916690-7071A874-200F-41F7-B6B4-F67024177461Q35996420-8B265FC8-B0E5-4D02-9BFE-E9A1EE766138Q35999008-3A204659-85FE-453A-AB7C-44EA2ADA3C5BQ36005091-864FFB7D-88D2-4F73-B849-3306E87FBD20Q36175090-62A79264-D6D2-42E0-AB6A-10FE70091500Q36182686-6E509053-E639-4847-8723-585102525794Q36297699-7E7DAF57-D498-4BE4-93A5-73040E9F50A8
P2860
Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Behavioral impact, acceptabili ...... sure chemoprophylaxis for HIV.
@en
Behavioral impact, acceptabili ...... sure chemoprophylaxis for HIV.
@nl
type
label
Behavioral impact, acceptabili ...... sure chemoprophylaxis for HIV.
@en
Behavioral impact, acceptabili ...... sure chemoprophylaxis for HIV.
@nl
prefLabel
Behavioral impact, acceptabili ...... sure chemoprophylaxis for HIV.
@en
Behavioral impact, acceptabili ...... sure chemoprophylaxis for HIV.
@nl
P2093
P1476
Behavioral impact, acceptabili ...... sure chemoprophylaxis for HIV.
@en
P2093
Aaron B Mendelsohn
Lee H Harrison
Mauro Schechter
Praca Onze Study Team
Regina F do Lago
Ronaldo I Moreira
P304
P356
10.1097/00126334-200404150-00010
P407
P577
2004-04-01T00:00:00Z